GO:0008277 regulation of G protein-coupled receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008277 describes any biological process that modulates the frequency, rate or extent of G protein-coupled receptor (GPCR) signaling, a central mechanism for cellular communication.
• GPCR signaling is regulated at multiple levels, including receptor phosphorylation by GRKs, arrestin recruitment, allosteric modulation, and feedback desensitization.
• This regulatory process controls diverse physiological outputs such as Hippo-YAP pathway activity, mTORC1 signaling, bile acid homeostasis, and neuroinflammatory responses.
• Dysregulation of GPCR signaling regulation is implicated in cancer, neurological disorders, metabolic diseases, and insecticide resistance.
• Key regulatory proteins include GRKs, arrestins, GPR39, GPR84, and downstream effectors like YAP and mTORC1.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of GPCR regulatory networks in disease contexts.
Description
G protein-coupled receptors (GPCRs) constitute the largest family of cell surface receptors and mediate cellular responses to hormones, neurotransmitters, and environmental cues. The biological process GO:0008277, regulation of G protein-coupled receptor signaling pathway, encompasses any mechanism that modulates the frequency, rate, or extent of GPCR signaling. This regulation is essential for maintaining cellular homeostasis and adapting to changing environments. Research has shown that GPCR signaling is tightly controlled by a network of regulatory proteins, including G protein-coupled receptor kinases (GRKs) and arrestins, which desensitize receptors and initiate alternative signaling cascades. Moreover, allosteric modulators can fine-tune receptor activity in a biased manner, offering new opportunities for drug discovery. The importance of this regulatory process extends to diverse physiological systems, from Hippo-YAP pathway control to mTORC1 regulation and bile acid metabolism. In this article, we provide a comprehensive overview of GO:0008277, covering its definition, mechanisms, key genes, disease relevance, and cutting-edge research methods including CRISPR-based models.
regulation of G protein-coupled receptor signaling pathway At A Glance
| GO ID | GO:0008277 |
|---|---|
| GO term | regulation of G protein-coupled receptor signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of GPCR protein signaling pathway; regulation of G protein coupled receptor protein signaling pathway; regulation of G-protein coupled receptor protein signaling pathway |
| Major function | Modulates the frequency, rate or extent of GPCR signaling, controlling cellular responses to external stimuli |
| Key regulators | GRKs, arrestins, allosteric modulators, GPR39, GPR84 |
| Downstream pathways | Hippo-YAP, mTORC1, bile acid signaling, neuroinflammation |
| Disease relevance | Cancer, neurological disorders, metabolic diseases, insecticide resistance |
What Is GO:0008277?
According to the Gene Ontology, GO:0008277 (regulation of G protein-coupled receptor signaling pathway) is defined as any process that modulates the frequency, rate or extent of G protein-coupled receptor signaling pathway. In other words, it includes all molecular events that control how strongly, how long, or how efficiently a GPCR transmits signals inside the cell. This regulation can occur at the level of receptor desensitization, internalization, recycling, or through interactions with accessory proteins and downstream effectors.
Why Is regulation of G protein-coupled receptor signaling pathway Important in Cell Biology?
Regulation of GPCR signaling is fundamental to physiology because it ensures that cellular responses to hormones, neurotransmitters, and other ligands are appropriately timed and terminated. Dysregulation of this process contributes to a wide range of pathologies, including cancer, neurological disorders, and metabolic diseases. Understanding the mechanisms of GPCR regulation is therefore critical for developing targeted therapeutics and for interpreting how cells integrate external signals.
• Controls the duration and intensity of GPCR-mediated signals, preventing overstimulation or desensitization.
• Integrates with major signaling hubs such as the Hippo-YAP pathway, influencing cell proliferation and organ size.
• Regulates mTORC1 activity, thereby impacting cell growth and metabolism.
• Modulates bile acid metabolism and signaling, affecting lipid and glucose homeostasis.
• Plays a role in neuroinflammation and neurological disease through receptors like GPR39.
• Influences inflammatory responses via receptors such as GPR84.
• Provides targets for biased allosteric modulators in drug discovery.
• Contributes to insecticide resistance mechanisms in pests.
• Essential for understanding feedback regulation by GRKs and arrestins.
• Offers opportunities for CRISPR-based functional genomics to identify novel regulatory components.
What Happens During regulation of G protein-coupled receptor signaling pathway?
Receptor Activation and G Protein Coupling
In simple terms: When a signal molecule binds to a GPCR, the receptor changes shape and activates G proteins inside the cell.
GPCR signaling begins with ligand binding, which induces conformational changes that allow the receptor to act as a guanine nucleotide exchange factor for heterotrimeric G proteins. This activation leads to the dissociation of Gα and Gβγ subunits, which then modulate downstream effectors such as adenylyl cyclase or phospholipase C. The regulation of this step can occur through allosteric modulators that enhance or inhibit coupling efficiency.
Phosphorylation by GRKs and Arrestin Recruitment
In simple terms: After activation, the receptor gets tagged with phosphate groups, which helps another protein called arrestin bind and shut off the signal.
G protein-coupled receptor kinases (GRKs) phosphorylate activated receptors at specific serine and threonine residues, creating binding sites for arrestins. Arrestin binding sterically hinders further G protein coupling and promotes receptor internalization via clathrin-coated pits. This feedback regulation is a primary mechanism for desensitization and is critical for preventing sustained signaling.
Receptor Internalization and Recycling
In simple terms: The receptor is pulled inside the cell, where it can either be broken down or sent back to the surface to work again.
Following arrestin recruitment, receptors are internalized into endosomes. Some receptors are dephosphorylated and recycled back to the plasma membrane, while others are targeted for lysosomal degradation. This trafficking determines the duration of signaling and the cell's ability to respond to subsequent stimuli. Regulatory proteins such as Rab GTPases and sorting nexins participate in these processes.
Allosteric Modulation and Biased Signaling
In simple terms: Some molecules can bind to a different site on the receptor and change which signaling pathways are turned on, without blocking the main binding site.
Allosteric modulators bind to sites distinct from the orthosteric ligand-binding pocket and can fine-tune receptor activity. Biased allosteric modulators preferentially activate certain signaling cascades (e.g., G protein-dependent vs. β-arrestin-dependent) over others. This offers a sophisticated layer of regulation that can be exploited therapeutically to achieve pathway-selective effects.
Cross-talk with Downstream Effectors
In simple terms: GPCR signals connect to other important pathways inside the cell, like those controlling growth or metabolism.
GPCR signaling intersects with major cellular pathways. For example, GPCR activation regulates the Hippo-YAP pathway, influencing gene expression related to proliferation and organ size. Additionally, GPCR signaling modulates mTORC1 activity, thereby affecting cell growth and autophagy. Bile acid signaling through GPCRs (e.g., TGR5) also regulates metabolic homeostasis. These cross-talk mechanisms are subject to regulation at multiple nodes.
Key Genes Involved in GO:0008277 regulation of G protein-coupled receptor signaling pathway
The following genes and proteins are key players in the regulation of GPCR signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRK2 | Phosphorylates activated GPCRs, promoting arrestin binding and desensitization | Target for modulating receptor responsiveness in heart failure and inflammation |
| ARRB1 | β-arrestin 1, scaffolds internalization and biased signaling | Biased agonism studies, drug discovery |
| ARRB2 | β-arrestin 2, regulates receptor trafficking and G protein-independent signaling | Neuropsychiatric and metabolic research |
| GPR39 | Zinc-sensing GPCR involved in neuroprotection and inflammation | Neurological disease models |
| GPR84 | Pro-inflammatory GPCR activated by medium-chain fatty acids | Inflammation and immune regulation |
| YAP1 | Downstream effector of GPCR-Hippo signaling, controls proliferation | Cancer and organ size studies |
| MTOR | Kinase regulated by GPCR signaling, central to growth control | Metabolism and cancer research |
| TGR5 | Bile acid receptor GPCR, regulates energy homeostasis | Metabolic disease models |
| GNAI1 | Gαi subunit, inhibits adenylyl cyclase | GPCR signaling specificity |
| GNAQ | Gαq subunit, activates phospholipase C | Cardiovascular and cancer research |
| ADRB2 | Prototypical GPCR, regulated by GRKs and arrestins | Asthma and cardiovascular studies |
| CXCR4 | Chemokine receptor, regulated by GRK/arrestin | Cancer metastasis and HIV research |
| OPRM1 | Mu-opioid receptor, subject to desensitization | Pain and addiction research |
| DRD2 | Dopamine receptor, regulated by GRKs | Schizophrenia and Parkinson's disease |
| HTR1A | Serotonin receptor, internalization regulated | Depression and anxiety models |
| AGTR1 | Angiotensin II receptor, regulated in hypertension | Cardiovascular disease |
| AVPR2 | Vasopressin receptor, mutations cause nephrogenic diabetes insipidus | Kidney function studies |
| FSHR | Follicle-stimulating hormone receptor, regulated in reproduction | Fertility research |
How Is regulation of G protein-coupled receptor signaling pathway Regulated?
The regulation of GPCR signaling is itself subject to multiple layers of control. GRK-mediated phosphorylation and arrestin recruitment provide rapid feedback desensitization. Allosteric modulators can either enhance or inhibit receptor activity in a pathway-selective manner. Additionally, downstream effectors such as mTORC1 and YAP integrate GPCR signals with cellular growth and metabolic programs. Bile acid signaling through GPCRs further exemplifies how systemic metabolic cues regulate this process.
regulation of G protein-coupled receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Cancer, organ size control | Knockout and overexpression in cancer cell lines |
| GPR39 | Neurological disorders, depression | Knockout mice and neuronal cell models |
| GPR84 | Inflammation, immune disorders | Knockout macrophages and inflammatory models |
| TGR5 | Metabolic syndrome, diabetes | Knockout mice and hepatocyte models |
| GRK2 | Heart failure, inflammation | Cardiomyocyte-specific knockout |
Cancer
Dysregulated GPCR signaling contributes to tumorigenesis through multiple mechanisms. GPCR-driven activation of the Hippo-YAP pathway promotes cell proliferation and survival, and aberrant GPCR signaling can activate mTORC1 to support anabolic growth. Targeting GPCR regulatory components, such as GRKs and arrestins, is being explored as a therapeutic strategy in various cancers.
Neurological Disorders
GPCRs such as GPR39 are implicated in neurological diseases, including depression, epilepsy, and Alzheimer's disease. GPR39 signaling modulates neuroinflammation and neuronal survival, and its dysregulation may contribute to disease pathogenesis. Regulation of GPCR signaling by GRKs and arrestins also affects neurotransmitter systems relevant to psychiatric disorders.
Metabolic and Inflammatory Diseases
Bile acid signaling through GPCRs like TGR5 regulates glucose and lipid metabolism, and its dysregulation is linked to obesity and type 2 diabetes. The pro-inflammatory GPCR GPR84 is involved in immune cell activation and inflammation, making it a potential target for inflammatory diseases.
Insecticide Resistance
GPCR signaling pathways play a role in insecticide resistance in pests, as highlighted by studies on resistance mechanisms. Understanding how GPCR regulation affects detoxification and target-site resistance can inform pest control strategies.
From regulation of G protein-coupled receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GRK2 mediate desensitization of a specific GPCR? | Knockout of GRK2 in cell lines followed by ligand stimulation |
| What is the role of a point mutation in a GPCR in biased signaling? | Point mutation knock-in using CRISPR |
| How does a tagged GPCR behave in live cells? | Knock-in of fluorescent tag (e.g., GFP) |
| What happens when a GPCR is overexpressed? | Overexpression via lentiviral transduction |
| Which genes regulate GPCR signaling in a genome-wide manner? | CRISPR library screening |
| How does a disease-associated GPCR variant affect signaling? | Knock-in of the variant in model organisms |
How to Study the regulation of G protein-coupled receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function phenotypes for all genes | Identify novel GPCR regulators |
| Phosphoproteomics | Global phosphorylation changes | Map GRK substrates and signaling networks |
| Live-cell imaging | Receptor localization and trafficking | Study internalization and recycling |
| BRET biosensors | G protein activation and arrestin recruitment | Quantify biased signaling |
| RNA-seq | Transcriptional changes | Downstream effects of GPCR regulation |
| Proximity labeling | Protein-protein interactions | Identify GPCR interactomes |
| Patch-clamp electrophysiology | Ion channel activity | GPCR regulation of neuronal excitability |
| Metabolic flux analysis | Cellular metabolism | GPCR control of metabolic pathways |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of GPCR signaling. These screens are particularly powerful for uncovering components of the desensitization and internalization machinery, as well as cross-talk with pathways like Hippo-YAP.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global mapping of phosphorylation events downstream of GPCR activation, including GRK-mediated receptor phosphorylation and downstream kinase cascades.
Live-Cell Imaging
Fluorescently tagged GPCRs and arrestins enable real-time visualization of receptor trafficking, internalization, and recycling. This approach provides spatiotemporal insights into regulation.
Biased Signaling Assays
Bioluminescence resonance energy transfer (BRET) and other assays can quantify G protein-dependent versus β-arrestin-dependent signaling, facilitating the study of allosteric modulators and biased agonists.
How CRISPR Can Be Used to Study GO:0008277 regulation of G protein-coupled receptor signaling pathway
Knockout
CRISPR knockout of GPCRs or their regulators (e.g., GRK2, β-arrestin) can reveal their essential roles in signaling. For example, knocking out GRK2 in cell lines abolishes agonist-induced desensitization, leading to prolonged signaling.
Point Mutation
Introducing point mutations in GPCRs or regulatory proteins can dissect specific phosphorylation sites or allosteric pockets. This is useful for studying biased signaling and disease-associated variants.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous GPCR loci allows real-time tracking of receptor trafficking and interaction with regulatory proteins under physiological expression levels.
Overexpression
Overexpression of GPCRs or their regulators via CRISPR activation (CRISPRa) or lentiviral delivery can model gain-of-function states and identify downstream effects, such as activation of YAP or mTORC1.
How EDITGENE Supports regulation of G protein-coupled receptor signaling pathway Research
Researchers studying regulation of G protein-coupled receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in receptor desensitization, internalization, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of G protein-coupled receptor signaling pathway research.
Frequently Asked Questions About regulation of G protein-coupled receptor signaling pathway
What is GO:0008277?
GO:0008277 is the Gene Ontology term for regulation of G protein-coupled receptor signaling pathway, defined as any process that modulates the frequency, rate or extent of GPCR signaling.
What genes are involved in regulation of GPCR signaling?
Key genes include GRK2, ARRB1, ARRB2, GPR39, GPR84, YAP1, MTOR, and TGR5, among others.
How does GRK regulate GPCR signaling?
GRKs phosphorylate activated GPCRs, promoting arrestin binding and desensitization, thereby terminating G protein signaling.
What is the role of arrestin in GPCR regulation?
Arrestins bind phosphorylated receptors, sterically blocking G protein coupling and initiating internalization and biased signaling.
How is GPCR signaling linked to cancer?
GPCR signaling can activate YAP and mTORC1, promoting proliferation and survival; dysregulation is common in cancer.
What diseases are associated with GPCR dysregulation?
Diseases include cancer, neurological disorders, metabolic syndrome, and inflammatory conditions.
How can CRISPR be used to study GPCR regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of GPCR regulatory mechanisms.
What are biased allosteric modulators?
They are molecules that bind to sites distinct from the orthosteric pocket and selectively activate certain GPCR signaling pathways.
What is the role of GPR39 in neurological diseases?
GPR39 modulates neuroinflammation and neuronal survival, and its dysregulation is implicated in depression and epilepsy.
How does GPCR signaling regulate metabolism?
GPCRs such as TGR5 regulate bile acid and glucose homeostasis, impacting metabolic diseases like diabetes.
Conclusion
GO:0008277, regulation of G protein-coupled receptor signaling pathway, is a critical biological process that controls cellular responses to a vast array of external signals. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and screening technologies are accelerating our understanding of this complex regulatory network. EDITGENE's services empower researchers to dissect these mechanisms with precision and scale.
References
- 1. Yu FX et al.. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.. Cell 150(4):780-91 PMID: 22863277
- 2. Melick CH et al.. 2022. G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation.. Mol Pharmacol 101(4):181-190 PMID: 34965982
- 3. Cao B et al.. 2023. Signaling pathway mechanisms of neurological diseases induced by G protein-coupled receptor 39.. CNS Neurosci Ther 29(6):1470-1483 PMID: 36942516
- 4. Chiang JY. 2013. Bile acid metabolism and signaling.. Compr Physiol 3(3):1191-212 PMID: 23897684
- 5. Marsango S et al.. 2024. Regulation of the pro-inflammatory G protein-coupled receptor GPR84.. Br J Pharmacol 181(10):1500-1508 PMID: 37085331
- 6. Black JB et al.. 2016. Feedback regulation of G protein-coupled receptor signaling by GRKs and arrestins.. Semin Cell Dev Biol 50:95-104 PMID: 26773211
- 7. Slosky LM et al.. 2021. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.. Trends Pharmacol Sci 42(4):283-299 PMID: 33581873
- 8. Li T et al.. 2019. Role of the G-Protein-Coupled Receptor Signaling Pathway in Insecticide Resistance.. Int J Mol Sci 20(17) PMID: 31484301
